Vis enkel innførsel

dc.contributor.authorNormand, Camilla Jacqueline Hansineen_US
dc.date.accessioned2020-09-02T08:03:01Z
dc.date.available2020-09-02T08:03:01Z
dc.date.issued2020-09-04
dc.date.submitted2020-08-19T14:29:10.603Z
dc.identifiercontainer/a9/56/8a/78/a9568a78-ed2c-48b2-a57c-87e68e5fb4f2
dc.identifier.isbn9788230853313en_US
dc.identifier.isbn9788230859476en_US
dc.identifier.urihttps://hdl.handle.net/1956/23954
dc.description.abstractBackground/Aims Cardiac Resynchronization Therapy (CRT) reduces morbidity and mortality in patients with heart failure and electrical dyssynchrony. Recommendations for which patients should receive a CRT device are outlined in cardiology society guidelines. However, these recommendations vary and for certain recommendations are imprecise. The purpose of this PhD is to explore why there are variations in international guideline recommendations and how these may contribute to differences in practice using the cohort of CRT Survey II with 11 088 patients in 42 European Society of Cardiology (ESC) member countries. Methods The recommendations provided by the major international guidelines were reviewed to identify areas of consistency and inconsistency in CRT recommendations. Data were collected on consecutive patients implanted with a CRT device in 42 ESC countries. These data were analysed to assess CRT practice and guideline adherence and relate them to variations in guideline recommendations. Results There was mainly consistency in the international guidelines regarding who should receive a device. However, some inconsistencies were identified. These included patients with non-left bundle branch block (LBBB) and patients with heart failure and a pacemaker requirement, implanted with a CRT to avoid right ventricular pacing dependence. Some of these inconsistencies could be explained by the timing of the release of the guidelines. However, others appeared to be related to CRT trial evidence being interpreted differently by different societies. In the European CRT population we found that implanters adhered well to European guidelines with only 2% of patients being implanted outside guideline recommendations. However, practice did vary in the different countries and these variations were more pronounced in areas where guideline recommendations are inconsistent or undetermined. Discussion Adherence to guidelines for CRT in Europe is high. However, in areas where there is limited CRT trial evidence this results in imprecise and inconsistent recommendations in international guidelines and may contribute to promoting variations in CRT practices in different countries.en_US
dc.language.isoengeng
dc.publisherThe University of Bergeneng
dc.relation.haspartPaper 1: Normand C, Linde C, Singh J, Dickstein K. Indications for Cardiac Resynchronization Therapy: A Comparison of the Major International Guidelines. JACC Heart Fail 2018;6(4):308- 316. The article is available in the main thesis. The article is also available at: <a href=" https://doi.org/10.1016/j.jchf.2018.01.022" target="blank"> https://doi.org/10.1016/j.jchf.2018.01.022</a>en_US
dc.relation.haspartPaper 2: Dickstein K, Normand C, Auricchio A, Bogale N, Cleland JG, Gitt AK, Stellbrink C, Anker SD, Filippatos G, Gasparini M, Hindricks G, Blomstrom Lundqvist C, Ponikowski P, Ruschitzka F, Botto GL, Bulava A, Duray G, Israel C, Leclercq C, Margitfalvi P, Cano O, Plummer C, Sarigul NU, Sterlinski M, Linde C. CRT Survey II: a European Society of Cardiology Survey of Cardiac Resynchronisation Therapy in 11 088 Patients-Who is Doing What to Whom and How? Eur J Heart Fail 2018;20(6):1039-1051. The article is available in the main thesis. The article is also available at: <a href="https://doi.org/10.1002/ejhf.1142" target="blank"> https://doi.org/10.1002/ejhf.1142</a>en_US
dc.relation.haspartPaper 3: Normand C, Linde C, Bogale N, Blomstrom-Lundqvist C, Auricchio A, Stellbrink C, Witte KK, Mullens W, Sticherling C, Marinskis G, Sciaraffia E, Papiashvili G, Iovev S, Dickstein K. Cardiac Resynchronization Therapy Pacemaker or Cardiac Resynchronization Therapy Defibrillator: What determines the choice?-Findings from the ESC CRT Survey II. Europace 2019;21(6):918-927. The article is not available in BORA due to publisher restrictions. The published version is available at: <a href="https://doi.org/10.1093/europace/euz002" target="blank">https://doi.org/10.1093/europace/euz002</a>en_US
dc.relation.haspartPaper 4: Normand C, Linde C, Blomström-Lundqvist C, Stellbrink C, Gasparini M, Anker S, Plummer C, Umutay Sarigul N, Papiashvili G, Iovev S, Dickstein K. Adherence to ESC Cardiac Resynchronization Therapy Guidelines – Findings from the ESC CRT Survey II. Europace 2020; 22(6):932–938. The article is not available in BORA due to publisher restrictions. The published version is available at: <a href="https://doi.org/10.1093/europace/euaa067" target="blank"> https://doi.org/10.1093/europace/euaa067</a>en_US
dc.rightsAttribution (CC BY) (applies to the main thesis, not the published articles)eng
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/eng
dc.titleCardiac Resynchronization Therapy (CRT): Patient Selection and Guideline Adherence : An Analysis of CRT Practice in Europe Based on the European Society of Cardiology CRT Survey II with 11088 patients in 42 countries.en_US
dc.typeDoctoral thesis
dc.date.updated2020-08-19T14:29:10.603Z
dc.rights.holderCopyright the Author.
dc.contributor.orcidhttps://orcid.org/0000-0002-0978-3449
fs.unitcode13-25-0


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution (CC BY) (applies to the main thesis, not the published articles)
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution (CC BY) (applies to the main thesis, not the published articles)